Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

The main objective of this study was to compare the long-term health-related quality of life of patients with acute promyelocytic leukemia (APL) treated with all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) vs ATRA plus standard chemotherapy. Patients previously enrolled in the randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Efficace, Fabio, Platzbecker, Uwe, Breccia, Massimo, Cottone, Francesco, Carluccio, Paola, Salutari, Prassede, Di Bona, Eros, Borlenghi, Erika, Autore, Francesco, Levato, Luciano, Finizio, Olimpia, Mancini, Valentina, D’Ardia, Stefano, Schlenk, Richard F., Melillo, Lorella, Fumagalli, Monica, Fiedler, Walter, Beltrami, Germana, Fracchiolla, Nicola Stefano, Bernardi, Massimo, Fazi, Paola, Annibali, Ombretta, Mayer, Karin, Voso, Maria Teresa, Vignetti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579253/
https://www.ncbi.nlm.nih.gov/pubmed/34529768
http://dx.doi.org/10.1182/bloodadvances.2021004649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579253/
https://www.ncbi.nlm.nih.gov/pubmed/34529768
http://dx.doi.org/10.1182/bloodadvances.2021004649

Ejemplares similares